Nabumetone Tillomed 500 mg Film-coated Tablets
500 milligram(s) Film-coated tablet
Compare
|
PA22720/001/001
Authorised: 14/07/2017
Tillomed Pharma GmbH
|
SPC
PIL
|
Nacsys 600 mg Effervescent Tablets
600 milligram(s) Effervescent tablet
Compare
|
PA2166/001/001
Authorised: 02/06/2017
Alpex Pharma (UK) Limited
|
SPC
PIL
|
Nadroparin calcium Aspen Forte 15,200 I.U. anti-Xa/0.8ml solution for injection in a pre-filled syringe.
15,200 international unit(s)/millilitre Solution for injection in pre-filled syringe
Compare
|
PA1691/019/002
Authorised: 04/05/2018
Aspen Pharma Trading Limited
|
SPC
PIL
|
Nadroparin calcium Aspen 2,850 I.U. anti-Xa/ 0.3 ml solution for injection in a pre-filled syringe
2,850 international unit(s) Solution for injection
Compare
|
PA1691/020/001
Authorised: 04/05/2018
Aspen Pharma Trading Limited
|
SPC
PIL
|
Nadroparin Calcium Aspen 3,800 I.U. anti-Xa/ 0.4 ml solution for injection in a pre-filled syringe
3,800 international unit(s) Solution for injection
Compare
|
PA1691/020/002
Authorised: 04/05/2018
Aspen Pharma Trading Limited
|
SPC
PIL
|
Nadroparin Calcium Aspen 5,700 I.U. anti-Xa/ 0.6 ml solution for injection in a pre-filled syringe
5,700 international unit(s) Solution for injection
Compare
|
PA1691/020/003
Authorised: 04/05/2018
Aspen Pharma Trading Limited
|
SPC
PIL
|
Nadroparin Calcium Aspen 7,600 I.U. anti-Xa/ 0.8 ml solution for injection in a pre-filled syringe
7,600 international unit(s) Solution for injection
Compare
|
PA1691/020/004
Authorised: 04/05/2018
Aspen Pharma Trading Limited
|
SPC
PIL
|
Nadroparin calcium Aspen 9,500 I.U. anti-Xa/ 1.0 ml solution for injection in a vial
9,500 international unit(s) Solution for injection
Compare
|
PA1691/021/001
Aspen Pharma Trading Limited
|
SPC
PIL
|
Nadroparin calcium Aspen 9,500 I.U. anti-Xa/ 1.0 ml solution for injection in a vial
9,500 international unit(s) Solution for injection
Compare
|
PA1691/021/002
Aspen Pharma Trading Limited
|
SPC
PIL
|
Nadroparin calcium Aspen Forte 11,400 I.U. anti-Xa/0.6ml solution for injection in a pre-filled syringe.
11,400 international unit(s)/millilitre Solution for injection in pre-filled syringe
Compare
|
PA1691/019/001
Authorised: 04/05/2018
Aspen Pharma Trading Limited
|
SPC
PIL
|
Nadroparin calcium Aspen Forte 19,000 I.U. anti-Xa/ml solution for injection in a pre-filled syringe
19,000 international unit(s)/millilitre Solution for injection in pre-filled syringe
Compare
|
PA1691/019/003
Authorised: 04/05/2018
Aspen Pharma Trading Limited
|
SPC
PIL
|
Naglazyme
1 milligram(s)/millilitre Concentrate for solution for infusion
Compare
|
EU/1/05/324/001
Authorised: 24/01/2006
BioMarin International Limited
|
SPC
PIL
IPAR
|
Nailderm 250 mg Tablets
250 milligram(s) Tablet
Compare
|
PA0577/068/001
Authorised: 17/06/2005
McDermott Laboratories Ltd., T/A Gerard Laboratories
|
SPC
PIL
|
Naloxone 400 microgram/ml solution for injection or infusion
400
microgram(s)/millilitre Solution for injection/infusion
Compare
|
PA1353/003/001
Authorised: 17/10/2008
Orpha-Devel Handels und Vertriebs GmbH
|
SPC
PIL
|
Naloxone 400 micrograms/ml solution for injection/infusion
400
microgram(s)/millilitre Solution for injection/infusion
Compare
|
PA0736/026/001
Authorised: 19/12/2007
B. Braun Melsungen AG
|
SPC
PIL
|
Naloxone Hydrochloride 400 micrograms/ml Solution for Injection or Infusion
400 microgram(s)/millilitre Solution for injection/infusion
Compare
|
PA0073/111/002
Authorised: 03/10/1989
Mercury Pharmaceuticals (Ireland) Ltd
|
SPC
|
Naloxone Hydrochloride Minijet 400 micrograms/ml Solution for injection
400 microgram(s)/millilitre Solution for injection
Compare
|
PA22684/003/001
Authorised: 18/04/1988
DLRC Pharma Services Limited
|
SPC
PIL
|
Naltrexone 50 mg film-coated tablets
50 milligram(s) Film-coated tablet
Compare
|
PA0934/003/001
Authorised: 11/03/2005
AOP Orphan Pharmaceuticals AG
|
SPC
PIL
|
Naltrexone Hydrochloride 50mg film-coated tablets
50 milligram(s) Film-coated tablet
Compare
|
PA2315/111/001
Authorised: 21/05/2010
Accord Healthcare Ireland Ltd.
|
SPC
PIL
|
Namuscla
167 milligram(s) Capsule, hard
Compare
|
EU/1/18/1325/001-004
Authorised: 18/12/2018
Lupin Europe GmbH
|
SPC
PIL
IPAR
|